Technology Transfer Forum at BIO 2002 in Toronto
WASHINGTON, D.C. (May 30, 2002) – The Biotechnology Industry Organization’s (BIO) annual meeting, BIO 2002 in Toronto, will feature a Technology Transfer Forum that will bring science and business together to speed commercialization of basic technology into useful consumer products. The Forum will allow universities, research institutions and non-profit organizations to showcase technologies available for licensing or commercialization to pharmaceutical and biotech companies, and other potential investors.
The three-day forum will feature more than 70 presentations and exhibits covering a broad spectrum of technologies, including drug delivery and discovery, infectious diseases, proteomics, bioinformatics, and genomics. Organizations from Canada, Australia, the Czech Republic, Finland, France, Germany, Sweden, Switzerland, the United Kingdom and the United States will participate in the forum.
BIO 2002 is the world’s largest biotechnology gathering with more than 14,000 industry leaders expected to attend. The conference will feature six plenary events, and more than 150 sessions and symposia, with 800 speakers covering 18 program tracks. The Technology Transfer Forum is part of the BIO 2002 Business Forum and will consist of 15-minute technology presentations and tabletop displays.
Presenting organizations from Canada include the University of British Columbia, Agriculture and AgriFood Canada, Lawson Health Research Institute, the Institute of Biological Sciences, the Hospital for Sick Children, the University of Toronto, the National Research Council of Canada, and McGill University. Other presenting organizations include the Centers for Disease Control & Prevention, Institut Pasteur, Johns Hopkins, the National Institutes of Health, the University of Sydney, the University of California, and Rockefeller University.
BIO 2002 registration for approved, credentialed media is complimentary and available on-site. For more information, please visit www.bio.org.
BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.
# # #